HICREN Biotech Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 111

Employees

  • Latest Deal Type
  • Series C1

  • Investors
  • 5

HICREN Biotech General Information

Description

Manufacturer of curved vertebroplasty products designed for orthopedic surgery. The company manufactures bone repair materials, sports medicine products, interspine implants, and endoscopy devices, providing doctors with robot-enabled orthopedic minimally invasive devices.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building 1, Zone B
  • Number 777, Binhai 4th Road, Qianwan New Area
  • Ningbo, Zhejiang 315336
  • China
+86 0574
Primary Industry
Surgical Devices
Vertical(s)
Corporate Office
  • Building 1, Zone B
  • Number 777, Binhai 4th Road, Qianwan New Area
  • Ningbo, Zhejiang 315336
  • China
+86 0574

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HICREN Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series C1) 19-May-2025 Completed Generating Revenue
5. Later Stage VC 23-Nov-2023 Completed Generating Revenue
4. Later Stage VC 14-Jul-2023 Completed Generating Revenue
3. Later Stage VC 13-Jul-2022 Completed Generating Revenue
2. Later Stage VC (Series B) 01-Jan-2021 $9.1M Completed Generating Revenue
1. Later Stage VC (Series A) 16-Jul-2018 $9.1M $9.1M Completed Generating Revenue
To view HICREN Biotech’s complete valuation and funding history, request access »

HICREN Biotech Patents

HICREN Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022062779-A1 Transpedicular intervertebral fusion system Inactive 23-Sep-2020
WO-2022062780-A1 Transpedicular vertebral body fusion surgical device Inactive 23-Sep-2020
WO-2021147582-A1 Percutaneous intervertebral fusion system Inactive 22-Jan-2020
EP-4085856-A1 Multifunctional vertebral body former Active 30-Dec-2019
EP-4085856-A4 Multifunctional vertebral body former Active 30-Dec-2019 A61B17/7061
To view HICREN Biotech’s complete patent history, request access »

HICREN Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HICREN Biotech Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Chengshu Capital Venture Capital Minority
Ningbo Qianwan Venture Capital Venture Capital Minority
Shenzhen High-Tech Investment Venture Capital Minority
Haichuang Group Corporation Minority
GP Capital (Shanghai) PE/Buyout Minority
To view HICREN Biotech’s complete investors history, request access »

HICREN Biotech Investments & Acquisitions (2)

HICREN Biotech’s most recent deal was a Merger/Acquisition with Sino-European Robotics. The deal was made on 12-Nov-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Sino-European Robotics 12-Nov-2024 Merger/Acquisition Computers, Parts and Peripherals
Sino-European Robotics 20-Dec-2021 Joint Venture Computers, Parts and Peripherals
To view HICREN Biotech’s complete investments and acquisitions history, request access »

HICREN Biotech Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Sino-European Robotics Shanghai, China 2021

HICREN Biotech FAQs

  • When was HICREN Biotech founded?

    HICREN Biotech was founded in 2011.

  • Where is HICREN Biotech headquartered?

    HICREN Biotech is headquartered in Ningbo, China.

  • What is the size of HICREN Biotech?

    HICREN Biotech has 111 total employees.

  • What industry is HICREN Biotech in?

    HICREN Biotech’s primary industry is Surgical Devices.

  • Is HICREN Biotech a private or public company?

    HICREN Biotech is a Private company.

  • What is HICREN Biotech’s current revenue?

    The current revenue for HICREN Biotech is .

  • How much funding has HICREN Biotech raised over time?

    HICREN Biotech has raised $24M.

  • Who are HICREN Biotech’s investors?

    Chengshu Capital, Ningbo Qianwan Venture Capital, Shenzhen High-Tech Investment, Haichuang Group, and GP Capital (Shanghai) have invested in HICREN Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process